English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
ASCO: Pemetrexed extends survival as maintenance therapy
Share :
2009 ASCO Annual Meeting
29 May - 2 Jun 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
18 Jun 2009
Views:
13182
Rating:
Save
Rate video
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
ASCO press conference: A phase III study reports that maintenance therapy with pemetrexed (Alimta) improves overall survival in nonsquamous forms of advanced NSCLC.
Categories:
Lung & pleura
Related Videos
WCI's role in the prevention of tobacco related cancer among Beedi rolling...
Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India
23 Oct 2024
Alternative livelihood training programme for rural women who are employed in...
Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India
23 Oct 2024
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...
18 Oct 2024
Predicting tumour mutations from pathology images may help increase...
Dr Rom Leidner - Providence Cancer Institute, Portland, USA
17 Oct 2024
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy...
Dr Li Zhang - Sun Yat-Sen University Cancer Centre, Guangzhou, China
9 Oct 2024
Tusamitamab ravtansine versus docetaxel in previously treated advanced...
Prof Benjamin Besse - Gustave Roussy, Paris, France
1 Oct 2024
Cemiplimab monotherapy could be a new treatment option for first line advanced...
Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia
1 Oct 2024
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
Amivantamab-lazertinib continue to show benefit as a first-line standard-of...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
More from
e
cancer